0001736153-25-000001.txt : 20250314
0001736153-25-000001.hdr.sgml : 20250314
20250314165341
ACCESSION NUMBER: 0001736153-25-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20250314
DATE AS OF CHANGE: 20250314
EFFECTIVENESS DATE: 20250314
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atomwise Inc.
CENTRAL INDEX KEY: 0001736153
ORGANIZATION NAME:
IRS NUMBER: 474869801
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-541006
FILM NUMBER: 25740995
BUSINESS ADDRESS:
STREET 1: 221 MAIN STREET, SUITE 1350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: (415) 890-5703
MAIL ADDRESS:
STREET 1: 221 MAIN STREET, SUITE 1350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
D
1
primary_doc.xml
X0708
D
LIVE
0001736153
Atomwise Inc.
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
(650) 449-7925
DELAWARE
None
None
Corporation
true
Stephen
Worland
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
Executive Officer
Director
Izhar
Wallach
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
Executive Officer
Director
Robert
Mittendorff
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
Director
Adam
Seabrook
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
Director
Linda
Maxwell
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
Director
Mike
Varney
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
Director
Yan
Zhao
250 Sutter St. Suite 650
SAN FRANCISCO
CA
CALIFORNIA
94108
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2024-03-08
false
true
true
Offer and sale of Series C Preferred Stock and Common Stock issuable upon conversion thereof. Certain outstanding shares of a specific series of Issuer's Preferred Stock were exchanged for shares of Issuer's Series C Preferred Stock for no consideration.
false
0
50000000
44282650
5717350
false
19
0
0
0
true
false
Atomwise Inc.
/s/ Stephen Worland
Stephen Worland
Chief Executive Officer
2025-03-14